PDFHydromorphone for Opioid Use Disorder
Early results of an Australian clinical trial of parenteral hydromorphone for Opioid Use Disorder.
Session date: May 22, 2024All links are direct pdf downloads of ECHO session presentations unless specified.
These files are provided for information only and are not intended to replace the clinical judgement of a practitioner. They should not be used alone to guide individual patient care.
Early results of an Australian clinical trial of parenteral hydromorphone for Opioid Use Disorder.
Session date: May 22, 2024Originally presented by Dr. Greta Moon
Session date: September 7, 2022Session 1 of our foundation series
Session date: January 20, 2021An overview of identifying and mitigating the risks of developing problematic opioid use.
Session date: November 4, 2020An overview of risk assessment in opioid use disorder and approaches to reducing risk.
Session date: February 13, 2019Assessing and managing risk in patients with opioid use disorder.
Session date: July 25, 2018